Spinocerebellar Ataxia Type 17
Neurology·MeSH: Trimethylaminuria
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Spinocerebellar Ataxia Type 17?
There are 1 clinical trial targeting Spinocerebellar Ataxia Type 17 tracked by BioSniper.
What is the prevalence of Spinocerebellar Ataxia Type 17?
The estimated prevalence of Spinocerebellar Ataxia Type 17 is approximately 0.5 per 100,000 population.
Deep-dive into Spinocerebellar Ataxia Type 17
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis